Sciencast Management’s Bristol-Myers Squibb BMY Stock Holding History

Sciencast Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-95,932	Closed	-$4.33M	–	302
2025 Q3	$4.33M	Buy	+95,932	New	+$4.48M	0.81%	51
2025 Q2	–	Sell	-4,255	Closed	-$260K	–	264
2025 Q1	$260K	Buy	+4,255	New	+$248K	0.06%	214
2024 Q1	–	Sell	-30,383	Closed	-$1.56M	–	221
2023 Q4	$1.56M	Sell	30,383 -2,072	-6%	-$109K	0.85%	19
2023 Q3	$1.88M	Buy	32,455 +14,412	+80%	+$883K	0.85%	7
2023 Q2	$1.14M	Buy	18,043 +12,296	+214%	+$825K	0.93%	18
2023 Q1	$390K	Buy	+5,747	New	+$405K	0.52%	91
2022 Q2	$3.29M	Sell	44,647 -4,647	-9%	-$354K	0.74%	35
2022 Q1	$3.7M	Buy	+49,294	New	+$3.31M	0.85%	3
2021 Q4	–	Sell	-24,783	Closed	-$1.41M	–	473
2021 Q3	$1.41M	Buy	+24,783	New	+$1.63M	0.4%	88
2020 Q3	–	Sell	-16,410	Closed	-$947K	–	397
2020 Q2	$947K	Buy	+16,410	New	+$982K	0.24%	142
2019 Q2	–	Sell	-33,293	Closed	-$1.53M	–	301
2019 Q1	$1.53M	Buy	+33,293	New	+$1.66M	0.54%	58
2018 Q2	–	Sell	-11,487	Closed	-$602K	–	261
2018 Q1	$602K	Buy	+11,487	New	+$739K	0.3%	125
2017 Q2	–	Sell	-14,534	Closed	-$790K	–	374
2017 Q1	$790K	Buy	14,534 +6,321	+77%	+$347K	0.44%	78
2016 Q4	$480K	Buy	+8,213	New	+$449K	0.65%	45

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Sciencast Management's BMY Position: Q4 2025 in Review

Sciencast Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 95,932 shares — an estimated $4.33M sold.

Sciencast Management first reported a position in BMY in Q4 2016 and held it in 14 quarters. The position peaked at $4.33M in Q3 2025. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

Sciencast Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
Sciencast Management sold 95,932 Bristol-Myers Squibb shares in Q4 2025, an estimated $4.33M.
Sciencast Management first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 14 quarters.
Sciencast Management's Bristol-Myers Squibb position peaked at $4.33M in Q3 2025.
2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Sciencast Management's 13F filing for Q4 2025, filed 17 Feb 2026.